| scholarly article | Q13442814 |
| P50 | author | Wen Wang | Q56990584 |
| Michael Costanzo | Q64022058 | ||
| Chad L Myers | Q88414136 | ||
| P2093 | author name string | Carol A Lange | |
| Charles Boone | |||
| Zack Z Xu | |||
| P2860 | cites work | Finding the missing heritability of complex diseases | Q22122198 |
| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| PGC-1 coactivators: inducible regulators of energy metabolism in health and disease | Q24541524 | ||
| KEGG: Kyoto Encyclopedia of Genes and Genomes | Q24548371 | ||
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
| The NHGRI GWAS Catalog, a curated resource of SNP-trait associations | Q24568334 | ||
| Genome-wide association study reveals genetic risk underlying Parkinson's disease | Q24646654 | ||
| The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. | Q54629037 | ||
| Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways | Q55554520 | ||
| Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast Cancer | Q56087735 | ||
| Expression of peroxisome-proliferator activated receptor-gamma (PPAR?) and the PPAR? co-activator, PGC-1, in human breast cancer correlates with clinical outcomes | Q61857372 | ||
| Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis | Q61873060 | ||
| Acute Myeloid Leukemia After Adjuvant Breast Cancer Therapy in Older Women: Understanding Risk | Q63365930 | ||
| Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women | Q79182457 | ||
| TLR9 and the recognition of self and non-self nucleic acids | Q79405093 | ||
| Reactome: a knowledgebase of biological pathways | Q24795413 | ||
| The genetic landscape of a cell | Q28131628 | ||
| Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1 | Q28207670 | ||
| Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer | Q28240593 | ||
| GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity | Q28275543 | ||
| A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer | Q28303909 | ||
| Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice | Q28368272 | ||
| The mystery of missing heritability: Genetic interactions create phantom heritability | Q28732355 | ||
| BOOST: A fast approach to detecting gene-gene interactions in genome-wide case-control studies | Q28749463 | ||
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
| Integrating common and rare genetic variation in diverse human populations | Q29547220 | ||
| Personal genomes: The case of the missing heritability | Q29614582 | ||
| Missing heritability and strategies for finding the underlying causes of complex disease | Q29614586 | ||
| Genome-wide association studies for common diseases and complex traits | Q29615822 | ||
| Glutathione transferases | Q29616501 | ||
| RUNX1 and its understudied role in breast cancer | Q30424533 | ||
| Hereditary breast cancer: ever more pieces to the polygenic puzzle | Q33356511 | ||
| RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland | Q33555996 | ||
| Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs | Q33568421 | ||
| Genetic interactions affecting human gene expression identified by variance association mapping | Q33597150 | ||
| Systematic interpretation of genetic interactions using protein networks | Q33622989 | ||
| Progesterone and breast cancer. | Q33687459 | ||
| Familial Risk and Heritability of Cancer Among Twins in Nordic Countries | Q33874409 | ||
| Toll-like receptor 9 in breast cancer | Q33928402 | ||
| Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. | Q33944747 | ||
| Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1. | Q34023796 | ||
| A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). | Q34085748 | ||
| Genome-wide association study identifies five new breast cancer susceptibility loci | Q34114293 | ||
| Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death | Q34123770 | ||
| Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans | Q34152058 | ||
| Finding the sources of missing heritability in a yeast cross | Q34325891 | ||
| Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression | Q34979352 | ||
| Detecting gene-gene interactions that underlie human diseases | Q34980492 | ||
| Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience | Q34996659 | ||
| A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population | Q35089479 | ||
| Putting genetic interactions in context through a global modular decomposition | Q35145534 | ||
| Incidence of acute myeloid leukemia after breast cancer | Q35640784 | ||
| A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer | Q35755874 | ||
| A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics | Q35786223 | ||
| The Nurses' Health Study: lifestyle and health among women | Q36111939 | ||
| Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians. | Q36227599 | ||
| Ultrafast genome-wide scan for SNP-SNP interactions in common complex disease | Q36354895 | ||
| A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. | Q36435849 | ||
| Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia | Q36450186 | ||
| Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. | Q36670312 | ||
| Genome-wide association analysis identifies three new breast cancer susceptibility loci | Q36842233 | ||
| Vitamin D signalling pathways in cancer: potential for anticancer therapeutics | Q36919979 | ||
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer | Q36956156 | ||
| Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases | Q37158199 | ||
| Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. | Q37356243 | ||
| Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines | Q37455274 | ||
| Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women | Q37467813 | ||
| Searching for missing heritability: designing rare variant association studies | Q37543773 | ||
| RETRACTED ARTICLE: Detection and replication of epistasis influencing transcription in humans | Q37699035 | ||
| The RUNX family: developmental regulators in cancer | Q38319972 | ||
| Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells | Q39086596 | ||
| A global genetic interaction network maps a wiring diagram of cellular function | Q39318959 | ||
| Mapping of signaling networks through synthetic genetic interaction analysis by RNAi | Q39580460 | ||
| The increased expression of peroxisome proliferator-activated receptor-gamma1 in human breast cancer is mediated by selective promoter usage | Q40525112 | ||
| Negative regulation of MEKK1-induced signaling by glutathione S-transferase Mu. | Q40527631 | ||
| Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta 12,14prostaglandin J2 (15-d-PGJ2). | Q40586826 | ||
| Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells | Q43006369 | ||
| Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer | Q44033535 | ||
| Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk | Q44085002 | ||
| Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study | Q44453199 | ||
| Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma. | Q44468885 | ||
| PPARgamma-PGC-1alpha activity is determinant of alcohol related breast cancer | Q44557888 | ||
| Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk | Q44770001 | ||
| Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis | Q44921278 | ||
| Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women | Q45188730 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P304 | page(s) | e1006973 | |
| P577 | publication date | 2017-09-28 | |
| P1433 | published in | PLOS Genetics | Q1893441 |
| P1476 | title | Pathway-based discovery of genetic interactions in breast cancer | |
| P478 | volume | 13 |
| Q90645991 | Complex Haplotypes of GSTM1 Gene Deletions Harbor Signatures of a Selective Sweep in East Asian Populations |
| Q97088693 | Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens |
| Q57108215 | Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses |
| Q59813527 | Epigenetic Factors and Mitochondrial Biology in Yeast: A New Paradigm for the Study of Cancer Metabolism? |
| Q93029325 | Genetic interaction networks in cancer cells |
| Q92555567 | Global Genetic Networks and the Genotype-to-Phenotype Relationship |
| Q64019134 | Integrating genetic and protein-protein interaction networks maps a functional wiring diagram of a cell |
| Q89187412 | Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls |
| Q99559613 | Systematic analysis of bypass suppression of essential genes |
| Q42366130 | Up For A Challenge (U4C): Stimulating innovation in breast cancer genetic epidemiology |
Search more.